The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms-Reference-Cited by-同舟云学术

The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms

Published:2008-06 Issue:6 Volume:39 Page:795-810
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Smith Cristina A.,Fan Guang

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference111 articles.

1. The Jak-Stat pathway in normal and perturbed hematopoiesis;Ward;Blood,2000

2. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl;Drachman;J Biol Chem,1995

3. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase;Argetsinger;Cell,1993

4. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis;Neubauer;Cell,1998

5. Jak2 is essential for signaling through a variety of cytokine receptors;Parganas;Cell,1998

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia;Nature Communications;2024-08-28

2. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement—A 10-case study and literature review;Human Pathology;2023-06

3. Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases;Frontiers in Oncology;2023-02-23

4. Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells;Methods in Cell Biology;2022

5. Oncogenic fusions JAK up CD8+ cytotoxic CTCL;Blood;2021-12-09